Is Collegium Pharmaceutical, Inc. (COLL) a Buy, Sell, or Hold?
NASDAQ : COLL
Collegium Pharmaceutical, Inc.
$36.08 USD
-$0.19 (-0.52%)
- Volume
- 316.58K
- Average Volume
- 439K
- Market Capitalization
- $1.17B
- P/E Ratio
- 15.22
- Dividend Yield
- 0.00%
- Price Target
- $58.00
- Year High
- $50.79
- Year Low
- $29.19
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.71
Insider Activity Summary (Last 12 Months)
Insiders Buying
26
Insiders Selling
38
Amount of Insider Selling
$482.46K
COLL Insider Buying/Selling by Quarter
COLL Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| SANTINI GINO | director | 2026-06-08 | M-Exempt | 16.49 | 2026-06-10 |
| SANTINI GINO | director | 2026-06-08 | M-Exempt | 16.49 | 2026-06-10 |
| Freund John Gordon | director | 2026-05-18 | S-Sale | 34.05 | 2026-05-20 |
| Lurker Nancy | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| Paya Carlos V | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| Freund John Gordon | director | 2026-05-15 | M-Exempt | 16.49 | 2026-05-18 |
| Freund John Gordon | director | 2026-05-15 | S-Sale | 34.54 | 2026-05-18 |
| Freund John Gordon | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| Freund John Gordon | director | 2026-05-15 | M-Exempt | 16.49 | 2026-05-18 |
| BOHLIN GAREN G | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| Glancy Donovan Michael | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| Balice-Gordon Rita J. | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| SANTINI GINO | director | 2026-05-14 | A-Award | 0 | 2026-05-18 |
| Glancy Donovan Michael | 2026-05-14 | 0 | 2026-05-18 | ||
| Lurker Nancy | director | 2026-05-13 | S-Sale | 35.9691 | 2026-05-15 |
| BOHLIN GAREN G | director | 2026-05-11 | M-Exempt | 16.49 | 2026-05-13 |
| BOHLIN GAREN G | director | 2026-05-11 | S-Sale | 37.1829 | 2026-05-13 |
| BOHLIN GAREN G | director | 2026-05-11 | M-Exempt | 16.49 | 2026-05-13 |
| Dieter David | officer: EVP & General Counsel | 2026-03-17 | F-InKind | 35.72 | 2026-04-03 |
| Dieter David | officer: EVP & General Counsel | 2026-03-18 | S-Sale | 34.9241 | 2026-03-20 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2026-03-03 | S-Sale | 40.3636 | 2026-03-05 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2026-03-03 | S-Sale | 40.9889 | 2026-03-05 |
| Dieter David | officer: EVP & General Counsel | 2026-02-10 | A-Award | 0 | 2026-02-12 |
| Dieter David | officer: EVP & General Counsel | 2026-02-10 | F-InKind | 46.75 | 2026-02-12 |
| Dieter David | officer: EVP & General Counsel | 2026-02-10 | A-Award | 0 | 2026-02-12 |
| Karnani Vikram | director, officer: President and CEO | 2026-02-10 | A-Award | 0 | 2026-02-12 |
| Karnani Vikram | director, officer: President and CEO | 2026-02-10 | F-InKind | 46.75 | 2026-02-12 |
| Karnani Vikram | director, officer: President and CEO | 2026-02-10 | A-Award | 0 | 2026-02-12 |
| Smith Thomas B | officer: EVP and Chief Medical Officer | 2026-02-10 | A-Award | 0 | 2026-02-12 |
| Smith Thomas B | officer: EVP and Chief Medical Officer | 2026-02-10 | F-InKind | 46.75 | 2026-02-12 |
| Smith Thomas B | officer: EVP and Chief Medical Officer | 2026-02-10 | F-InKind | 46.75 | 2026-02-12 |
| Smith Thomas B | officer: EVP and Chief Medical Officer | 2026-02-10 | A-Award | 0 | 2026-02-12 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2026-02-10 | A-Award | 0 | 2026-02-12 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2026-02-10 | F-InKind | 46.75 | 2026-02-12 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2026-02-10 | A-Award | 0 | 2026-02-12 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2026-02-10 | F-InKind | 46.75 | 2026-02-12 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2026-02-10 | A-Award | 0 | 2026-02-12 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2026-02-10 | F-InKind | 46.75 | 2026-02-12 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2026-02-10 | A-Award | 0 | 2026-02-12 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2026-02-10 | F-InKind | 46.75 | 2026-02-12 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-12-08 | M-Exempt | 15.9 | 2025-12-10 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-12-08 | S-Sale | 47.8895 | 2025-12-10 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-12-08 | S-Sale | 48.6617 | 2025-12-10 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-12-08 | M-Exempt | 15.9 | 2025-12-10 |
| Balice-Gordon Rita J. | director | 2025-12-05 | S-Sale | 47.0338 | 2025-12-09 |
| Karnani Vikram | director, officer: President and CEO | 2025-11-12 | F-InKind | 47.35 | 2025-11-14 |
| Fallon John A. | director | 2025-11-12 | M-Exempt | 9.33 | 2025-11-14 |
| Fallon John A. | director | 2025-11-12 | M-Exempt | 16.49 | 2025-11-14 |
| Fallon John A. | director | 2025-11-12 | S-Sale | 47.2136 | 2025-11-14 |
| Fallon John A. | director | 2025-11-12 | M-Exempt | 16.49 | 2025-11-14 |
| Fallon John A. | director | 2025-11-12 | M-Exempt | 9.33 | 2025-11-14 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2025-11-06 | S-Sale | 40.3801 | 2025-11-07 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2025-11-06 | S-Sale | 41.2756 | 2025-11-07 |
| Smith Thomas B | officer: EVP and Chief Medical Officer | 2025-08-29 | S-Sale | 38.4241 | 2025-09-03 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-08-18 | M-Exempt | 21.34 | 2025-08-20 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-08-18 | S-Sale | 38.2068 | 2025-08-20 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-08-18 | M-Exempt | 21.34 | 2025-08-20 |
| SANTINI GINO | director | 2025-08-15 | M-Exempt | 13.45 | 2025-08-19 |
| SANTINI GINO | director | 2025-08-15 | S-Sale | 37.1912 | 2025-08-19 |
| SANTINI GINO | director | 2025-08-15 | M-Exempt | 13.45 | 2025-08-19 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-08-13 | M-Exempt | 21.34 | 2025-08-15 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-08-13 | S-Sale | 38.0335 | 2025-08-15 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-08-13 | M-Exempt | 21.34 | 2025-08-15 |
| Rubric Capital Management LP | 10 percent owner | 2025-08-13 | S-Sale | 37.85 | 2025-08-15 |
| Rubric Capital Management LP | 10 percent owner | 2025-08-07 | 0 | 2025-08-15 | |
| Freund John Gordon | director | 2025-08-08 | S-Sale | 34.3632 | 2025-08-12 |
| Freund John Gordon | director | 2025-06-09 | M-Exempt | 13.45 | 2025-06-11 |
| Freund John Gordon | director | 2025-06-09 | S-Sale | 30.624 | 2025-06-11 |
| Freund John Gordon | director | 2025-06-09 | M-Exempt | 13.45 | 2025-06-11 |
| Fallon John A. | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| Lurker Nancy | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| BOHLIN GAREN G | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| Balice-Gordon Rita J. | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| Freund John Gordon | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| SANTINI GINO | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| Paya Carlos V | director | 2025-05-15 | A-Award | 0 | 2025-05-19 |
| Paya Carlos V | director: | 2025-05-15 | 0 | 2025-05-19 | |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2025-03-20 | S-Sale | 30.0011 | 2025-03-24 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2025-03-21 | S-Sale | 30.0295 | 2025-03-24 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-03-20 | S-Sale | 30.0005 | 2025-03-24 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-03-21 | S-Sale | 30.0293 | 2025-03-24 |
| Dieter David | officer: EVP & General Counsel | 2025-03-17 | A-Award | 0 | 2025-03-19 |
| Dieter David | officer | 2025-03-17 | 0 | 2025-03-19 | |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-03-11 | S-Sale | 30.004 | 2025-03-18 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2025-03-14 | S-Sale | 30.0034 | 2025-03-18 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-03-14 | S-Sale | 30.0049 | 2025-03-18 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-03-06 | S-Sale | 30.004 | 2025-03-13 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2025-03-11 | S-Sale | 30.006 | 2025-03-13 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2025-03-06 | S-Sale | 30 | 2025-03-10 |
| Tupper Colleen | officer: EVP & Chief Financial Officer | 2025-03-07 | S-Sale | 30.0007 | 2025-03-10 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-03-06 | S-Sale | 30.0011 | 2025-03-10 |
| Dreyer Scott | officer: EVP & Chief Commercial Officer | 2025-03-07 | S-Sale | 30.0025 | 2025-03-10 |
| Kuhlmann Shirley R. | officer: EVP and General Counsel | 2025-03-04 | M-Exempt | 24.03 | 2025-03-06 |
| Kuhlmann Shirley R. | officer: EVP and General Counsel | 2025-03-04 | S-Sale | 28.079 | 2025-03-06 |
| Kuhlmann Shirley R. | officer: EVP and General Counsel | 2025-03-05 | S-Sale | 28.0264 | 2025-03-06 |
| Kuhlmann Shirley R. | officer: EVP and General Counsel | 2025-03-06 | S-Sale | 28.5014 | 2025-03-06 |
| Kuhlmann Shirley R. | officer: EVP and General Counsel | 2025-03-04 | M-Exempt | 24.03 | 2025-03-06 |
| Heffernan Michael Thomas | director | 2025-02-10 | A-Award | 0 | 2025-02-12 |
| Smith Thomas B | officer: EVP and Chief Medical Officer | 2025-02-10 | A-Award | 0 | 2025-02-12 |
| Smith Thomas B | officer: EVP and Chief Medical Officer | 2025-02-10 | F-InKind | 30.52 | 2025-02-12 |